Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

INTRODUCTION: Patients with plaque psoriasis often have nail psoriasis, which is difficult to treat. Ixekizumab (IXE) and ustekinumab (UST) are biologics with established efficacy in nail psoriasis. We present post hoc data from a head-to-head trial of IXE and UST (IXORA-S) to examine the efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasel, Norman, Thaçi, Diamant, French, Lars E., Conrad, Curdin, Dutronc, Yves, Gallo, Gaia, Berggren, Lovisa, Lacour, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367982/
https://www.ncbi.nlm.nih.gov/pubmed/32415575
http://dx.doi.org/10.1007/s13555-020-00383-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367982/
https://www.ncbi.nlm.nih.gov/pubmed/32415575
http://dx.doi.org/10.1007/s13555-020-00383-x

Ejemplares similares